BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32182223)

  • 1. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation.
    Bhargava P; Smith MD; Mische L; Harrington E; Fitzgerald KC; Martin K; Kim S; Reyes AA; Gonzalez-Cardona J; Volsko C; Tripathi A; Singh S; Varanasi K; Lord HN; Meyers K; Taylor M; Gharagozloo M; Sotirchos ES; Nourbakhsh B; Dutta R; Mowry EM; Waubant E; Calabresi PA
    J Clin Invest; 2020 Jul; 130(7):3467-3482. PubMed ID: 32182223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells.
    Yanguas-Casás N; Barreda-Manso MA; Nieto-Sampedro M; Romero-Ramírez L
    J Cell Physiol; 2017 Aug; 232(8):2231-2245. PubMed ID: 27987324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurochenodeoxycholic acid reduces astrocytic neuroinflammation and alleviates experimental autoimmune encephalomyelitis in mice.
    Xu N; Bai Y; Han X; Yuan J; Wang L; He Y; Yang L; Wu H; Shi H; Wu X
    Immunobiology; 2023 May; 228(3):152388. PubMed ID: 37079985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial control of astrocytes in response to microbial metabolites.
    Rothhammer V; Borucki DM; Tjon EC; Takenaka MC; Chao CC; Ardura-Fabregat A; de Lima KA; Gutiérrez-Vázquez C; Hewson P; Staszewski O; Blain M; Healy L; Neziraj T; Borio M; Wheeler M; Dragin LL; Laplaud DA; Antel J; Alvarez JI; Prinz M; Quintana FJ
    Nature; 2018 May; 557(7707):724-728. PubMed ID: 29769726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation.
    Yanguas-Casás N; Barreda-Manso MA; Nieto-Sampedro M; Romero-Ramírez L
    J Neuroinflammation; 2014 Mar; 11():50. PubMed ID: 24645669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions.
    Wetzels S; Vanmierlo T; Scheijen JLJM; van Horssen J; Amor S; Somers V; Schalkwijk CG; Hendriks JJA; Wouters K
    Front Immunol; 2019; 10():855. PubMed ID: 31068938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D
    Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
    Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
    Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Functionally Defined
    Groves A; Kihara Y; Jonnalagadda D; Rivera R; Kennedy G; Mayford M; Chun J
    eNeuro; 2018; 5(5):. PubMed ID: 30255127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic receptors in multiple sclerosis pathogenesis.
    Domercq M; Zabala A; Matute C
    Brain Res Bull; 2019 Sep; 151():38-45. PubMed ID: 30500565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astroglial and Microglial Purinergic P2X7 Receptor as a Major Contributor to Neuroinflammation during the Course of Multiple Sclerosis.
    Sidoryk-Węgrzynowicz M; Strużyńska L
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: role of cyclooxygenase-2.
    Palumbo S; Bosetti F
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):273-8. PubMed ID: 24095587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
    Costa C; Martínez-Sáez E; Gutiérrez-Franco A; Eixarch H; Castro Z; Ortega-Aznar A; Ramón Y Cajal S; Montalban X; Espejo C
    Mult Scler; 2015 Nov; 21(13):1632-43. PubMed ID: 26432853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.
    Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN
    J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis.
    Absinta M; Maric D; Gharagozloo M; Garton T; Smith MD; Jin J; Fitzgerald KC; Song A; Liu P; Lin JP; Wu T; Johnson KR; McGavern DB; Schafer DP; Calabresi PA; Reich DS
    Nature; 2021 Sep; 597(7878):709-714. PubMed ID: 34497421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy.
    Mendes MO; Rosa AI; Carvalho AN; Nunes MJ; Dionísio P; Rodrigues E; Costa D; Duarte-Silva S; Maciel P; Rodrigues CMP; Gama MJ; Castro-Caldas M
    Mol Cell Neurosci; 2019 Apr; 96():1-9. PubMed ID: 30771505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
    Tsutsui S; Schnermann J; Noorbakhsh F; Henry S; Yong VW; Winston BW; Warren K; Power C
    J Neurosci; 2004 Feb; 24(6):1521-9. PubMed ID: 14960625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.